4H-Furo[3,2-d]-1,3,2-dioxaphosphorin, Adenosine deriv.; Bucladesine Sodium; Bucladesine Sodium Salt; DC 2797; Dibutyryl 3',5'-Cyclic AMP Sodium Salt; Dibutyryl Cyclic AMP Monosodium Salt; Dibutyryl Cyclic AMP Sodium; Dibutyryl Cyclic AMP Sodium Salt; Dibutyryl-cAMP Sodium Salt; Monosodium Dibutyryl Cyclic AMP; N-6,O-2'-Dibutyryladenosine Cyclic 3',5'-Monophosphate Sodium Salt; N6,2'-O-Dibutyryl-3',5'-cyclic AMP Sodium Salt; N6,2'-O-Dibutyryladenosine-3',5'-monophosphate Monosodium Salt; N6,O2'-Dibutyryl-3',5'-cyclic AMP Sodium Salt; Sodium N6,2'-O-dibutyryladenosine 3',5'-Cyclic Phosphate; Sodium Dibutyryl 3',5'-Cyclic AMP; Sodium Dibutyryl cAMP; N-(9-?-D-Ribofuranosyl-9H-purin-6-yl)-butyramide Cyclic Hydrogen Phosphate Butyrate (ester), Monosodium Salt
Bucladesine Sodium Salt is a fully characterized chemical compound used as a reference standard of API Bucladesine. The standard offered is compliant with regulatory guidelines. Bucladesine Sodium Salt is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 16980-89-5
